GO:0004062 aryl sulfotransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004062 aryl sulfotransferase activity catalyzes the transfer of a sulfonate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to a phenol, producing an aryl sulfate and adenosine 3',5'-bisphosphate.
• This activity is central to the phase II metabolism of phenolic xenobiotics, neurotransmitters, and drugs, influencing their bioavailability and excretion.
• The human SULT1A1 enzyme is a major aryl sulfotransferase that sulfonates small phenols and estrogens, and its expression varies widely among individuals.
• Bacterial aryl sulfotransferases can use PAPS-independent mechanisms, linking sulfonation to disulfide bond formation and redox homeostasis.
• Small molecules and allosteres can modulate aryl sulfotransferase activity, offering tools to control neurotransmitter sulfonation.
• Engineered aryl sulfotransferases are being developed for the biosynthesis of glycosaminoglycans, expanding their biotechnological applications.
Description
Aryl sulfotransferase activity (GO:0004062) is a molecular function that catalyzes the transfer of a sulfonate group from the universal sulfate donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to a phenolic acceptor, yielding an aryl sulfate and adenosine 3',5'-bisphosphate. This reaction is a key component of phase II drug metabolism and is involved in the detoxification and bioactivation of numerous endogenous and exogenous compounds. The activity is widely distributed across species, from bacteria to humans, and plays critical roles in neurotransmitter regulation, hormone homeostasis, and xenobiotic clearance. Researchers study aryl sulfotransferase activity to understand drug metabolism, endocrine disruption, and the mechanisms of sulfonation-related diseases. The enzyme's ability to modify phenolic substrates also makes it a target for engineering novel biocatalysts and for developing therapeutic strategies.
aryl sulfotransferase activity At A Glance
| GO ID | GO:0004062 |
|---|---|
| GO term | aryl sulfotransferase activity |
| Ontology | molecular_function |
| Synonym | phenol sulfotransferase activity; arylsulfotransferase; PST; sulfokinase activity; dopamine sulfotransferase activity |
| Major function | Transfer of sulfonate from PAPS to phenolic substrates, forming aryl sulfates |
| Reaction | 3'-phosphoadenosine 5'-phosphosulfate + a phenol = adenosine 3',5'-bisphosphate + an aryl sulfate |
| Cofactor | 3'-phosphoadenosine 5'-phosphosulfate (PAPS) |
| Substrate class | Phenols, catecholamines, xenobiotics, drugs |
| Localization | Cytosol (in eukaryotic cells) |
What Is GO:0004062?
Aryl sulfotransferase activity (GO:0004062) is defined as the catalysis of the reaction: 3'-phosphoadenosine 5'-phosphosulfate (PAPS) + a phenol = adenosine 3',5'-bisphosphate + an aryl sulfate. In other words, it is the enzyme activity that transfers a sulfonate group from PAPS to a phenolic compound, forming a sulfate ester. This activity is synonymous with phenol sulfotransferase, aryl sulphotransferase, and several other names reflecting its substrate specificity.
Why Is aryl sulfotransferase activity Important in Cell Biology?
Aryl sulfotransferase activity is essential for the metabolism and detoxification of a wide range of phenolic compounds, including drugs, hormones, and neurotransmitters. By adding a sulfate group, it increases the water solubility of these molecules, facilitating their excretion. This activity also regulates the biological activity of signaling molecules such as dopamine and other catecholamines, thereby impacting neuronal function. In addition, aryl sulfotransferases are involved in the activation of procarcinogens and in the biosynthesis of sulfated glycosaminoglycans, making them relevant to cancer research and biotechnology.
• Detoxifies phenolic xenobiotics and drugs by increasing their water solubility.
• Regulates neurotransmitter levels, including dopamine, through sulfonation.
• Modulates the activity of steroid hormones such as estrogens.
• Plays a role in the bioactivation of certain procarcinogens.
• Contributes to the biosynthesis of sulfated glycosaminoglycans.
• Exhibits genetic polymorphisms that affect drug response and disease risk.
• Is a target for small-molecule allosteric regulation.
• Bacterial aryl sulfotransferases link sulfonation to disulfide bond formation.
• Engineered variants enable biocatalytic production of sulfated compounds.
• Provides a model for studying enzyme evolution and substrate specificity.
Mechanism, Genes and Research Methods
What Happens During aryl sulfotransferase activity?
In simple terms: The enzyme takes a sulfate group from PAPS and attaches it to a phenol, making the phenol more water-soluble.
The catalytic cycle begins with the binding of the cofactor PAPS and a phenolic substrate to the enzyme's active site. The enzyme then facilitates the transfer of the sulfonate group from PAPS to the phenolic oxygen, forming an aryl sulfate and releasing adenosine 3',5'-bisphosphate. This reaction is a nucleophilic substitution where the phenolic oxygen attacks the sulfur atom of PAPS. The mechanism is conserved among cytosolic sulfotransferases, although the exact residues involved in catalysis vary among isoforms.
Substrate Recognition and Specificity
In simple terms: Different aryl sulfotransferases prefer different phenols, which determines which compounds they modify.
Aryl sulfotransferases exhibit broad but distinct substrate specificities. For example, human SULT1A1 preferentially sulfonates small planar phenols such as p-nitrophenol and estradiol, while other isoforms may favor larger or more complex substrates. The substrate specificity is determined by the size and shape of the active site pocket and by specific amino acid residues that interact with the phenolic ring. Bacterial aryl sulfotransferases can utilize a wider range of substrates and may even act on tyrosine residues in proteins.
Cofactor PAPS and Its Role
In simple terms: PAPS is the sulfate donor; without it, the reaction cannot proceed.
3'-Phosphoadenosine 5'-phosphosulfate (PAPS) is the universal sulfate donor for all sulfotransferases. It is synthesized from ATP and inorganic sulfate in a two-step pathway. The binding of PAPS to the enzyme induces conformational changes that position the sulfonate group for transfer. PAPS levels can be limiting under certain conditions, and the enzyme's affinity for PAPS varies among isoforms.
Regulation of Aryl Sulfotransferase Activity
In simple terms: The activity can be turned up or down by other molecules that bind to the enzyme.
Aryl sulfotransferase activity is regulated at multiple levels, including transcriptional control, post-translational modifications, and allosteric modulation. Small molecules can act as allosteres to either enhance or inhibit sulfonation of neurotransmitters, providing a means to fine-tune signaling. For instance, certain compounds have been shown to modulate dopamine sulfonation by binding to an allosteric site on the enzyme. Additionally, genetic polymorphisms in SULT genes can lead to differences in enzyme activity among individuals.
Structural Features of Aryl Sulfotransferases
In simple terms: The enzyme has a pocket that holds PAPS and the phenol, and its shape determines what it can modify.
Cytosolic sulfotransferases share a common structural fold consisting of a single alpha/beta domain with a central five-stranded parallel beta-sheet. The PAPS-binding site is highly conserved, while the substrate-binding pocket is more variable, accounting for differences in substrate specificity. The active site often contains a catalytic histidine residue that acts as a general base to deprotonate the phenolic hydroxyl, facilitating the nucleophilic attack on PAPS. Bacterial aryl sulfotransferases may have a different fold and use a cysteine residue for catalysis.
Key Genes Involved in GO:0004062 aryl sulfotransferase activity
The following genes encode enzymes with aryl sulfotransferase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SULT1A1 | Major human phenol sulfotransferase; sulfonates small phenols and estrogens | Drug metabolism, hormone regulation, cancer risk |
| SULT1A2 | Human phenol sulfotransferase; sulfonates xenobiotics | Xenobiotic metabolism, genetic polymorphisms |
| SULT1A3 | Human dopamine sulfotransferase; sulfonates catecholamines | Neurotransmitter regulation, Parkinson's disease |
| SULT1B1 | Human thyroid hormone sulfotransferase | Thyroid hormone homeostasis |
| SULT1E1 | Human estrogen sulfotransferase | Estrogen homeostasis, breast cancer |
| SULT2A1 | Human dehydroepiandrosterone sulfotransferase | Steroid hormone metabolism |
| SULT4A1 | Brain-specific sulfotransferase | Neurotransmitter regulation |
| SULT6B1 | Sulfotransferase with unknown endogenous substrate | Orphan enzyme research |
| PAPSS1 | PAPS synthase 1; synthesizes PAPS | Cofactor supply for sulfonation |
| PAPSS2 | PAPS synthase 2; synthesizes PAPS | Cofactor supply, cartilage development |
| Renilla muelleri ST | Coelenterazine sulfotransferase from Renilla | Bioluminescence, enzyme evolution |
| E. coli aslA | PAPS-independent aryl sulfotransferase | Disulfide bond formation, redox biology |
| Engineered SULT | Engineered aryl sulfotransferase for glycosaminoglycan biosynthesis | Biocatalysis, glycoengineering |
| SULT1C2 | Sulfotransferase with broad substrate specificity | Xenobiotic metabolism |
| SULT1D1 | Rodent-specific sulfotransferase | Model organism studies |
| SULT3A1 | Sulfotransferase with unknown function | Orphan enzyme research |
| SULT2B1 | Cholesterol sulfotransferase | Lipid metabolism |
How Is aryl sulfotransferase activity Regulated?
Aryl sulfotransferase activity is regulated at transcriptional, post-transcriptional, and post-translational levels. Small-molecule allosteres can directly modulate enzyme activity, as shown for neurotransmitter sulfonation. For example, certain compounds bind to an allosteric site on SULT1A3 and enhance or inhibit dopamine sulfonation. Additionally, PAPS availability, which depends on PAPS synthase expression and sulfate uptake, can limit sulfonation rates. Genetic polymorphisms in SULT genes also contribute to interindividual variability in enzyme activity.
aryl sulfotransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SULT1A1 | Breast cancer, colorectal cancer | Knockout or point-mutation in cell lines (e.g., MCF-7) |
| SULT1A3 | Parkinson's disease, schizophrenia | Overexpression or knockout in neuronal cells |
| SULT1E1 | Endometrial cancer, breast cancer | Knock-in of variant alleles in cancer cell lines |
| SULT1B1 | Thyroid disorders | Knockout in thyroid cell lines |
| E. coli aslA | Bacterial virulence | Knockout in pathogenic bacteria |
Aryl Sulfotransferase Activity in Cancer
Altered aryl sulfotransferase activity has been implicated in cancer risk and progression. SULT1A1 polymorphisms affect the metabolism of estrogens and procarcinogens, influencing breast and colorectal cancer susceptibility. Sulfonation can either detoxify or activate carcinogens, depending on the substrate. In addition, estrogen sulfotransferase (SULT1E1) regulates estrogen levels, and its dysregulation is associated with hormone-dependent cancers.
Neurotransmitter Sulfonation and Neurological Disorders
Aryl sulfotransferases, particularly SULT1A3 and SULT4A1, sulfonate neurotransmitters such as dopamine, norepinephrine, and serotonin, modulating their activity. Dysregulation of this process has been linked to neurological and psychiatric disorders, including Parkinson's disease and schizophrenia. Small molecules that modulate sulfonation could offer therapeutic avenues for these conditions.
Aryl Sulfotransferase Activity in Metabolic and Inflammatory Diseases
Sulfonation of thyroid hormones by SULT1B1 affects thyroid hormone homeostasis, and altered activity may contribute to thyroid disorders. In inflammatory conditions, sulfonation of catecholamines can influence immune cell function. Furthermore, bacterial aryl sulfotransferases involved in disulfide bond formation are important for the virulence of pathogenic bacteria, making them potential antibacterial targets.
From aryl sulfotransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SULT1A1 knockout alter drug metabolism? | SULT1A1 knockout cell line (e.g., HepG2) |
| How do polymorphisms affect enzyme activity? | Point mutation knock-in of SULT1A1 variants |
| Can engineered SULT improve glycosaminoglycan production? | Overexpression of engineered SULT in CHO cells |
| What is the role of SULT1A3 in dopamine sulfonation? | SULT1A3 knockout or overexpression in neuroblastoma cells |
| How does bacterial aryl sulfotransferase affect disulfide bond formation? | Knockout of aslA in E. coli |
| Can allosteres modulate neurotransmitter sulfonation? | Tagged knock-in of SULT1A3 for FRET-based assays |
How to Study the aryl sulfotransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Colorimetric assay with p-nitrophenol | Formation of p-nitrophenyl sulfate | Kinetic studies, inhibitor screening |
| Radiolabeled PAPS assay | Incorporation of 35S into phenolic substrates | Enzyme activity in tissue extracts |
| CRISPR/Cas9 knockout | Loss of specific SULT gene function | Isoform-specific roles in drug metabolism |
| RNA-seq | Expression levels of SULT genes | Tissue-specific expression, disease profiling |
| X-ray crystallography | Three-dimensional structure of enzyme-substrate complex | Mechanistic studies, structure-based drug design |
| Isothermal titration calorimetry | Binding affinity for PAPS or substrates | Substrate specificity analysis |
| High-throughput fluorescence assay | Allosteric modulation of sulfonation | Small-molecule screening |
| Genotyping | SULT gene polymorphisms | Association studies with disease risk |
Enzymatic Assays for Aryl Sulfotransferase Activity
Aryl sulfotransferase activity is commonly measured using radiolabeled PAPS or colorimetric substrates such as p-nitrophenol. The reaction can be monitored by the formation of p-nitrophenyl sulfate, which absorbs at 400 nm. Alternatively, radioactive [35S]PAPS can be used, followed by thin-layer chromatography or liquid scintillation counting. These assays are suitable for kinetic studies and inhibitor screening.
Genetic and Genomic Approaches
Knockout or knockdown of SULT genes using CRISPR/Cas9 or RNA interference allows researchers to study the contribution of specific isoforms to total sulfotransferase activity. Quantitative PCR and RNA-seq can measure SULT gene expression levels in tissues or cell lines. Polymorphism analysis by genotyping is used to link genetic variants to enzyme activity and disease risk.
Structural and Biophysical Methods
X-ray crystallography and NMR spectroscopy have been used to determine the structures of aryl sulfotransferases and to map substrate-binding sites. Isothermal titration calorimetry and surface plasmon resonance can measure binding affinities for PAPS and substrates. These methods help elucidate the molecular basis of substrate specificity and catalysis.
Small-Molecule Screening and Allostery
High-throughput screening of small-molecule libraries can identify allosteric modulators of aryl sulfotransferase activity. For example, a fluorescence-based assay using a sulfotransferase-coupled enzyme system has been developed to screen for compounds that alter dopamine sulfonation. Such screens can uncover chemical probes to study sulfonation in vivo.
How CRISPR Can Be Used to Study GO:0004062 aryl sulfotransferase activity
Knockout
CRISPR/Cas9-mediated knockout of SULT genes, such as SULT1A1 or SULT1A3, enables researchers to eliminate specific aryl sulfotransferase activity and study its contribution to drug metabolism, neurotransmitter regulation, and disease. Knockout cell lines can be used to assess the impact of sulfonation on xenobiotic toxicity and hormone signaling.
Point Mutation
Introducing point mutations that mimic naturally occurring polymorphisms (e.g., SULT1A1*2) allows functional characterization of variant enzymes. CRISPR-based base editing or homology-directed repair can create isogenic cell lines carrying specific mutations, facilitating studies on altered substrate specificity or catalytic efficiency.
Knock-in
Knock-in of tagged SULT genes (e.g., GFP or FLAG) enables real-time tracking of enzyme localization and interaction partners. Knock-in of engineered SULT variants can be used to produce sulfated glycosaminoglycans in cells, as demonstrated for biotechnological applications.
Overexpression
Overexpression of aryl sulfotransferases in cell lines or model organisms can enhance sulfonation capacity, useful for studying metabolic pathways and for producing sulfated compounds. For example, overexpression of engineered SULT in CHO cells improves glycosaminoglycan biosynthesis. Overexpression can also be used to study the effects of increased sulfonation on neurotransmitter signaling.
How EDITGENE Supports aryl sulfotransferase activity Research
Researchers studying aryl sulfotransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic or disease phenotype. EDITGENE provides comprehensive CRISPR-based services to create knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling precise functional studies of SULT genes and their variants.
Contact EDITGENE today to design your custom CRISPR model for aryl sulfotransferase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SULT1E1 Knockout HEK293 Cell Line | EDJ-KQ5855 | Human | 6783 | Details Get a Quote |
| SULT1A2 Knockout HEK293 Cell Line | EDJ-KQ5859 | Human | 6799 | Details Get a Quote |
| SULT1A1 Knockout HEK293 Cell Line | EDJ-KQ5864 | Human | 6817 | Details Get a Quote |
| SULT1B1 Knockout HEK293 Cell Line | EDJ-KQ8742 | Human | 27284 | Details Get a Quote |
| SULT1C2 Knockout HEK293 Cell Line | EDJ-KQ14783 | Human | 6819 | Details Get a Quote |
| SULT1A4 Knockout HEK293 Cell Line | EDJ-KQ15561 | Human | 445329 | Details Get a Quote |
| SULT1C3 Knockout HEK293 Cell Line | EDJ-KQ15563 | Human | 442038 | Details Get a Quote |
| SULT1E1 Knockout HeLa Cell Line | EDJ-KQ29327 | Human | 6783 | Details Get a Quote |
| SULT1A2 Knockout HeLa Cell Line | EDJ-KQ29337 | Human | 6799 | Details Get a Quote |
| SULT1A1 Knockout A-549 Cell Line | EDJ-KQ29348 | Human | 6817 | Details Get a Quote |
| SULT1A1 Knockout HCT 116 Cell Line | EDJ-KQ29349 | Human | 6817 | Details Get a Quote |
| SULT1A1 Knockout HeLa Cell Line | EDJ-KQ29350 | Human | 6817 | Details Get a Quote |
| SULT1A4 Knockout A-549 Cell Line | EDJ-KQ46418 | Human | 445329 | Details Get a Quote |
| SULT1A4 Knockout HCT 116 Cell Line | EDJ-KQ46419 | Human | 445329 | Details Get a Quote |
| SULT1A4 Knockout HeLa Cell Line | EDJ-KQ46420 | Human | 445329 | Details Get a Quote |
Displaying Records 1 To 15 Of 36 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About aryl sulfotransferase activity
What is aryl sulfotransferase activity?
Aryl sulfotransferase activity (GO:0004062) is the enzyme activity that transfers a sulfonate group from PAPS to a phenol, forming an aryl sulfate and adenosine 3',5'-bisphosphate.
What genes are involved in aryl sulfotransferase activity?
Key genes include SULT1A1, SULT1A3, SULT1E1, and other SULT family members, as well as PAPSS1 and PAPSS2 for PAPS synthesis.
What is the function of SULT1A1?
SULT1A1 is a major human phenol sulfotransferase that sulfonates small phenols, estrogens, and drugs, affecting their activity and excretion.
How is aryl sulfotransferase activity measured?
It is measured using colorimetric assays with p-nitrophenol or radiolabeled PAPS, followed by detection of the sulfated product.
What diseases are associated with aryl sulfotransferase activity?
Altered activity is linked to cancer, neurological disorders, and thyroid dysfunction, among others.
Can aryl sulfotransferase activity be regulated by small molecules?
Yes, allosteric modulators can enhance or inhibit the enzyme, as shown for neurotransmitter sulfonation.
What is the role of PAPS in aryl sulfotransferase activity?
PAPS is the sulfate donor; it binds to the enzyme and provides the sulfonate group for transfer to the phenolic substrate.
Are there bacterial aryl sulfotransferases?
Yes, bacteria such as E. coli have PAPS-independent aryl sulfotransferases involved in disulfide bond formation.
How can CRISPR be used to study aryl sulfotransferase activity?
CRISPR can create knockout, point-mutation, knock-in, or overexpression models to dissect the function of specific SULT genes.
What is the clinical relevance of SULT polymorphisms?
Polymorphisms in SULT genes can affect drug metabolism and disease susceptibility, making them important for personalized medicine.
Conclusion
Aryl sulfotransferase activity (GO:0004062) is a fundamental enzymatic function that modulates the biological activity of numerous phenolic compounds, from neurotransmitters to drugs and hormones. Its roles in detoxification, hormone regulation, and disease make it a critical area of research. Understanding the mechanisms, genes, and regulation of aryl sulfotransferases can lead to new therapeutic strategies and biotechnological applications. EDITGENE's CRISPR services provide powerful tools to investigate these enzymes and their variants in relevant cell models.
References
- 1. Tzertzinis G et al.. 2022. Coelenterazine sulfotransferase from Renilla muelleri.. PLoS One 17(10):e0276315 PMID: 36251663
- 2. Zhou Y et al.. 2026. An engineered aryl sulfotransferase for the biosynthesis of glycosaminoglycans.. Int J Biol Macromol 373:153181 PMID: 42342182
- 3. Cook I et al.. 2021. Small-molecule control of neurotransmitter sulfonation.. J Biol Chem 296:100094 PMID: 33485192
- 4. Sheng JJ et al.. 2001. Measurement of aryl and alcohol sulfotransferase activity.. Curr Protoc Toxicol Chapter 4:Unit4.5 PMID: 20945296
- 5. Darrah K et al.. 2019. Allosteres to regulate neurotransmitter sulfonation.. J Biol Chem 294(7):2293-2301 PMID: 30545938
- 6. Duffel MW. 1994. Molecular specificity of aryl sulfotransferase IV (tyrosine-ester sulfotransferase) for xenobiotic substrates and inhibitors.. Chem Biol Interact 92(1-3):3-14 PMID: 8033263
- 7. Hempel N et al.. 2007. Human cytosolic sulfotransferase SULT1A1.. Int J Biochem Cell Biol 39(4):685-9 PMID: 17110154
- 8. Malojcić G et al.. 2010. The PAPS-independent aryl sulfotransferase and the alternative disulfide bond formation system in pathogenic bacteria.. Antioxid Redox Signal 13(8):1247-59 PMID: 20136513
